A cohort study in Taiwan suggested that among patients with atrial fibrillation (AF) with prior ICH, non–vitamin K antagonist oral anticoagulants (NOACs) use was associated with lower rates of intracranial hemorrhage (ICH) and major bleeding compared with warfarin use, whereas the rate of ischemic stroke was similar. The study included 4540 patients (mean age, 76.0 years; 58.4% men), with 1047 patients receiving warfarin (mean age, 75.1 years; 54.5% men) and 3493 patients receiving NOACs (mean age, 76.3 years; 59.6% men). Compared with warfarin use, NOACs use was associated with statistically significantly lower risk of all-cause mortality (adjusted hazard ratio [aHR], 0.517), ICH (aHR, 0.556), and major bleeding (aHR, 0.645), whereas the rate of ischemic stroke was similar in the 2 groups (aHR, 0.879). The results were generally consistent after propensity score matching among 973 patients in each group. The findings suggest that NOACs could be the preferred choice for stroke prevention in AF patients with prior ICH. Source: https://zh.jamanetwork.com/
A study comparing UK adults conceived just before or after sugar rationing ended found that…
A Chinese nationwide case-crossover study revealed that lower temperatures were associated with higher risks of…
A prospective cohort study suggests that personal exposure to brighter nights and darker days causes…
Both clinician-rated and patient-reported outcomes suggested that mindfulness-based stress reduction (MBSR) was well-tolerated with comparable…
The number of individuals with high blood pressure (BP) is increasing worldwide. The trajectory of…
A single combined measure of high-sensitivity C-reactive protein (CRP), low-density lipoprotein (LDL) cholesterol, and lipoprotein(a)…
This website uses cookies.